2026 Yoshihiro Oka: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	58	3528	3254	140	128	211	11715

Overview

Yoshihiro Oka is affiliated with Osaka University in Japan and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans diverse subfields including Molecular Biology, Immunology, Reproductive Medicine, Oncology, and Social Psychology.

The scientist's research extensively explores topics such as hypothalamic control of reproductive hormones, renal and related cancers, immunotherapy and immune responses, CAR-T cell therapy research, cancer immunotherapy and biomarkers, neuroendocrine regulation and behavior, and reproductive biology and its impacts on aquatic species.

Frequent coauthors collaborating with Yoshihiro Oka include Haruo Sugiyama, Yusuke Oji, Akihiro Tsuboi, Hiroko Nakajima, and Jun Nakata. Together, their work has been published in several scientific venues, with multiple articles appearing in Cancer Immunology Immunotherapy, bioRxiv (Cold Spring Harbor Laboratory), Current Medicinal Chemistry, ZOOLOGICAL SCIENCE, and Journal of Neuroendocrinology.

Selected recent papers authored by or involving Yoshihiro Oka include:

TMC4 is a novel chloride channel involved in high-concentration salt taste sensation (2021, The Journal of Physiological Sciences)
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain (2022, Science Translational Medicine)
Multiple gonadotropin-releasing hormone systems in non-mammalian vertebrates: Ontogeny, anatomy, and physiology (2021, Journal of Neuroendocrinology)
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer (2021, Journal of Immunotherapy)
Estrogen upregulates the firing activity of hypothalamic gonadotropin-releasing hormone (GnRH1) neurons in the evening in female medaka (2022, Journal of Neuroendocrinology)

Best Publications

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

Yoshihiro Oka;Akihiro Tsuboi;Tetsuya Taguchi;Tadashi Osaki

838
Citations
Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

Kazushi Inoue;Hiroyasu Ogawa;Hiroyasu Ogawa;Yoshiaki Sonoda;Yoshiaki Sonoda;Takafumi Kimura;Takafumi Kimura

482
Citations
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

460
Citations
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.

Yoshihiro Oka;Olga A. Elisseeva;Akihiro Tsuboi;Hiroyasu Ogawa

401
Citations
Immunohistochemical detection of WT1 protein in a variety of cancer cells

Shin-ichi Nakatsuka;Yusuke Oji;Tetsuya Horiuchi;Takayoshi Kanda

394
Citations
Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product

Yoshihiro Oka;Keiko Udaka;Akihiro Tsuboi;Olga A. Elisseeva

339
Citations
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.

Hiroyasu Ogawa;Hiroya Tamaki;Kazuhiro Ikegame;Toshihiro Soma

333
Citations
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

Yusuke Oji;Shinichiro Miyoshi;Hajime Maeda;Seiji Hayashi

295
Citations
Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

Kazushi Inoue;Hiroya Tamaki;Hiroyasu Ogawa;Yoshihiro Oka

250
Citations
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

231
Citations
Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies.

Olga A. Elisseeva;Yoshihiro Oka;Akihiro Tsuboi;Kiyoyuki Ogata

190
Citations
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.

Yusuke Oji;Shoji Nakamori;Masahiro Fujikawa;Shin-ichi Nakatsuka

177
Citations
Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

Naoki Hosen;Yoshiaki Sonoda;Yusuke Oji;Takafumi Kimura

174
Citations
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors

Yusuke Oji;Tsuyoshi Suzuki;Yoko Nakano;Motohiko Maruno

171
Citations
The activated conformation of integrin β 7 is a novel multiple myeloma–specific target for CAR T cell therapy

Naoki Hosen;Yukiko Matsunaga;Kana Hasegawa;Hiroshi Matsuno

166
Citations
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

Akihiro Tsuboi;Yoshihiro Oka;Keiko Udaka;Masaki Murakami

164
Citations
Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma

Yusuke Oji;Hirofumi Yamamoto;Masaya Nomura;Yoko Nakano

162
Citations
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

Sumiyuki Nishida;Naoki Hosen;Toshiaki Shirakata;Keisuke Kanato

162
Citations
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

Yoshihiro Oka;Akihiro Tsuboi;Masaki Murakami;Manabu Hirai

161
Citations
WT1 peptide vaccine for the treatment of cancer.

Yoshihiro Oka;Akihiro Tsuboi;Yusuke Oji;Ichiro Kawase

161
Citations
Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).

Akihiro Tsuboi;Yoshihiro Oka;Hiroyasu Ogawa;Olga A Elisseeva

153
Citations

Frequent Co-Authors

Haruo Sugiyama Osaka University

Yusuke Oji Osaka University

Atsushi Kumanogoh Osaka University

Katsuyuki Aozasa Osaka University

Satoshi Morita Kyoto University

Tadamitsu Kishimoto Osaka University

Masaki Yasukawa Ehime University

Eiichi Morii Osaka University

Shinzaburo Noguchi Osaka University

Toshihisa Komori Nagasaki University

External Links

Personal website of Yoshihiro Oka

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open diverse career opportunities. For individuals interested in advancing their clinical skills, accelerated NP programs offer a fast track to becoming a Nurse Practitioner. This pathway is especially valuable for those looking to transition quickly into high-demand roles.

Nurses aiming to specialize further can consider acute care certification for FNP, which equips Family Nurse Practitioners with the skills needed to manage complex patient cases in acute settings. This additional credential expands career options significantly.

For those starting from scratch, the best online BSN programs for non nurses provide an accessible route to enter the nursing field without prior healthcare experience. These programs are designed to build foundational knowledge effectively through online learning formats.

Salary transparency is vital when planning your career path. Understanding DNP salary transparency across states helps prospective students make informed decisions about where to study and work after graduation, optimizing both educational investment and future earnings.

To explore these opportunities further, visit accelerated NP program, acute care certification for FNP, best online BSN programs for non nurses, and DNP salary transparency.